Psarras A, Emery P, Vital EM. Type I interferon-mediated autoimmune diseases: pathogenesis, diagnosis and targeted therapy. Rheumatology (Oxford). 2017;56:1662–75.

CAS  PubMed  Google Scholar 

Crouse J, Kalinke U, Oxenius A. Regulation of antiviral T cell responses by type I interferons. Nat Rev Immunol. 2015;15:231–42.

Article  CAS  PubMed  Google Scholar 

Bezalel S, Guri KM, Elbirt D, Asher I, Sthoeger ZM. Type I interferon signature in systemic lupus erythematosus. Isr Med Assoc J. 2014;16:246–9.

PubMed  Google Scholar 

Ronnblom L, Alm GV. An etiopathogenic role for the type I IFN system in SLE. Trends Immunol. 2001;22:427–31.

Article  CAS  PubMed  Google Scholar 

Jiang J, Zhao M, Chang C, Wu H, Lu Q. Type I interferons in the pathogenesis and treatment of autoimmune diseases. Clin Rev Allergy Immunol. 2020;59:248–72.

Article  CAS  PubMed  Google Scholar 

Finke D, Randers K, Hoerster R, Hennig H, Zawatzky R, Marion T, et al. Elevated levels of endogenous apoptotic DNA and IFN-alpha in complement C4-deficient mice: implications for induction of systemic lupus erythematosus. Eur J Immunol. 2007;37:1702–9.

Article  CAS  PubMed  Google Scholar 

Cetin Gedik K, Lamot L, Romano M, Demirkaya E, Piskin D, Torreggiani S, et al. The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE/PRAAS SAVI and AGS. Ann Rheum Dis. 2022;81:601–13.

Article  PubMed  Google Scholar 

Lovgren T, Eloranta ML, Bave U, Alm GV, Ronnblom L. Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthr Rheum. 2004;50:1861–72.

Article  Google Scholar 

Feng D, Stone RC, Eloranta ML, Sangster-Guity N, Nordmark G, Sigurdsson S, et al. Genetic variants and disease-associated factors contribute to enhanced interferon regulatory factor 5 expression in blood cells of patients with systemic lupus erythematosus. Arthr Rheum. 2010;62:562–73.

Article  CAS  Google Scholar 

Remmers EF, Plenge RM, Lee AT, Graham RR, Hom G, Behrens TW, et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med. 2007;357:977–86.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu M, Guo Q, Wu C, Sterlin D, Goswami S, Zhang Y, et al. Type I interferons promote the survival and proinflammatory properties of transitional B cells in systemic lupus erythematosus patients. Cell Mol Immunol. 2019;16:367–79.

Article  CAS  PubMed  Google Scholar 

Dong X, Antao OQ, Song W, Sanchez GM, Zembrzuski K, Koumpouras F, et al. Type I interferon-activated STAT4 regulation of follicular helper T cell-dependent cytokine and immunoglobulin production in lupus. Arthr Rheumatol. 2021;73:478–89.

Article  CAS  Google Scholar 

Buang N, Tapeng L, Gray V, Sardini A, Whilding C, Lightstone L, et al. Type I interferons affect the metabolic fitness of CD8+ T cells from patients with systemic lupus erythematosus. Nat Commun. 2021;12:1980.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Crow MK. Type I interferon in the pathogenesis of lupus. J Immunol. 2014;192:5459–68.

Article  CAS  PubMed  Google Scholar 

Eloranta ML, Alm GV, Ronnblom L. Disease mechanisms in rheumatology–tools and pathways: plasmacytoid dendritic cells and their role in autoimmune rheumatic diseases. Arthr Rheum. 2013;65:853–63.

Article  CAS  Google Scholar 

Vance RE. Cytosolic DNA sensing: the field narrows. Immunity. 2016;45:227–8.

Article  CAS  PubMed  Google Scholar 

Sakaguchi S, Negishi H, Asagiri M, Nakajima C, Mizutani T, Takaoka A, et al. Essential role of IRF-3 in lipopolysaccharide-induced interferon-beta gene expression and endotoxin shock. Biochem Biophys Res Commun. 2003;306:860–6.

Article  CAS  PubMed  Google Scholar 

Tesser A, Piperno GM, Pin A, Piscianz E, Boz V, Benvenuti F, et al. Priming of the cGAS-STING-TBK1 pathway enhances LPS-induced release of type I interferons. Cells. 2021;10:785.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Garcia-Romo GS, Caielli S, Vega B, Connolly J, Allantaz F, Xu Z, et al. Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med. 2011. https://doi.org/10.1126/scitranslmed.3001201.

Article  PubMed  PubMed Central  Google Scholar 

Boiteux S, Radicella JP. The human OGG1 gene: structure, functions, and its implication in the process of carcinogenesis. Arch Biochem Biophys. 2000;377:1–8.

Article  CAS  PubMed  Google Scholar 

Tumurkhuu G, Chen S, Montano EN, Ercan Laguna D, De Los SG, Yu JM, et al. Oxidative DNA damage accelerates skin inflammation in pristane-induced lupus model. Front Immunol. 2020;11:554725.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jiang SH, Athanasopoulos V, Ellyard JI, Chuah A, Cappello J, Cook A, et al. Functional rare and low frequency variants in BLK and BANK1 contribute to human lupus. Nat Commun. 2019;10:2201.

Article  PubMed  PubMed Central  Google Scholar 

Xie C, Zhou H, Athanasopoulos V, Shen Q, Zhang Y, Meng X, et al. De novo PACSIN1 gene variant found in childhood lupus and a role for PACSIN1/TRAF4 complex in toll-like receptor 7 activation. Arthr Rheumatol. 2023;75:1058–71.

Article  CAS  Google Scholar 

Eames HL, Corbin AL, Udalova IA. Interferon regulatory factor 5 in human autoimmunity and murine models of autoimmune disease. Transl Res. 2016;167:167–82.

Article  CAS  PubMed  Google Scholar 

Sigurdsson S, Nordmark G, Goring HH, Lindroos K, Wiman AC, Sturfelt G, et al. Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet. 2005;76:528–37.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sigurdsson S, Goring HH, Kristjansdottir G, Milani L, Nordmark G, Sandling JK, et al. Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus. Hum Mol Genet. 2008;17:872–81.

Article  CAS  PubMed  Google Scholar 

Graham RR, Kozyrev SV, Baechler EC, Reddy MV, Plenge RM, Bauer JW, et al. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet. 2006;38:550–5.

Article  CAS  PubMed  Google Scholar 

Graham RR, Kyogoku C, Sigurdsson S, Vlasova IA, Davies LR, Baechler EC, et al. Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc Natl Acad Sci U S A. 2007;104:6758–63.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lofgren SE, Yin H, Delgado-Vega AM, Sanchez E, Lewen S, Pons-Estel BA, et al. Promoter insertion/deletion in the IRF5 gene is highly associated with susceptibility to systemic lupus erythematosus in distinct populations, but exerts a modest effect on gene expression in peripheral blood mononuclear cells. J Rheumatol. 2010;37:574–8.

Article  PubMed  Google Scholar 

Li D, Matta B, Song S, Nelson V, Diggins K, Simpfendorfer KR, et al. IRF5 genetic risk variants drive myeloid-specific IRF5 hyperactivation and presymptomatic SLE. JCI Insight. 2020;5:e124020.

Article  PubMed  PubMed Central  Google Scholar 

Contreras-Cubas C, Garcia-Ortiz H, Velazquez-Cruz R, Barajas-Olmos F, Baca P, Martinez-Hernandez A, et al. Catalytically impaired TYK2 variants are protective against childhood- and adult-onset systemic lupus erythematosus in Mexicans. Sci Rep. 2019;9:12165.